28th Congress on Atherosclerosis: What did 2024 bring to dyslipidemia treatment?
Authors:
Kristýna Čillíková
Published in:
AtheroRev 2025; 10(1): 69-71
Category:
Annoucements
Labels
Angiology Diabetology Internal medicine Cardiology General practitioner for adultsArticle was published in
Athero Review
2025 Issue 1
Most read in this issue
- Targeting lipoprotein(a): modification of cardiovascular risk and current treatment options
- The use of fenofibrate in the prevention of diabetic retinopathy progression: an interdisciplinary consensus
- SAA Consensus Statement EAS 2021: Triglyceride-rich lipoproteins and their remnant particles – a review of metabolism, role in atherosclerotic cardiovascular disease, and new therapeutic strategies
- Cardiovascular risk in obese individuals: how to keep it under control?